Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Nu Skin Gains From Product Launches, Currency Rates Hurt

Published 07/08/2019, 05:53 AM
Updated 07/09/2023, 06:31 AM

Adverse currency headwinds and a sluggish view are making matters worse for Nu Skin Enterprises, Inc. (NYSE:NUS) . Nevertheless, the well-known beauty company is striving to stay afloat on the back of a sturdy customer base and effective product launches. Let’s take a closer look.

Strong Customer Base & Growth Efforts

Nu Skin sells and distributes its products through a network of sales leaders and customers across 50 markets globally. Notably, the company’s top line has been consistently benefitting from growth in consumer count. In the first quarter of 2019, customer base increased 10% to 1,193,206.

This uptick followed after improvements of 16%, 9%, 8% and 7% in the fourth, the third, the second and the first quarter of 2018, respectively. The company relies on social media as well as well-knit product and marketing programs to expand customer reach.

Moreover, with the help of advanced technology and well-strategized product programs, Nu Skin tries to capture greater market share and sustain momentum. In fact, the company’s long-term strategies are based on three pillars — Products, Programs and Platforms. Notably, the launch of the revolutionary ageLOC LumiSpa has been a success. LumiSpa is expected to drive growth in 2019 as well.

Apart from launches, Nu Skin’s well-knit product strategies are driving growth in several market locations. The company has been working to expand sales compensation program, Velocity, across various nations. Management expects that Velocity will be a significant component in the company’s business expansion in the future. Additionally, it focuses on expansion of global beauty device systems on the back of product introductions and line extensions.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .



Headwinds

A major portion of Nu Skin’s revenues is sourced from international markets, which exposes it to significant currency risks. In fact, the company’s top and the bottom line in the first quarter were considerably hurt by foreign currency headwinds. During the quarter, revenue growth was impaired by currency headwinds of approximately 6%. Moreover, management expects foreign currency fluctuations to affect the top line in 2019 by 2-3%.

Adverse currency is likely to weigh on the company’s second-quarter outcome. Management anticipates revenues of $660-$680 million, which indicates 3-6% decline from the year-ago quarter’s level. This includes an expected 4-5% negative foreign currency impact.

Also, the company highlighted that revenues in the prior-year quarter gained from the introduction of LumiSpa in Mainland China. The introduction generated sales of approximately $95 million, consequently making the year-over-year comparison a bit challenging.

Well, such headwinds have exerted pressure on the company’s shares that declined 6.8% in the past three months compared with the industry’s rise of 10.8%.

Wrapping Up

Clearly, adverse impacts from currency are major concerns for Nu Skin. Nevertheless, prudent product expansion efforts along with optimization of the Velocity sales compensation program are expected to provide some cushion from the aforementioned headwinds. Such upsides are likely to aid the Zacks Rank #3 (Hold) company to make a comeback to investors’ good books.

Looks for Consumer Staples Stocks? Check These

Avon Products (NYSE:AVP) has long-term earnings per share growth rate of 7.5% and a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Campbell Soup Co. (NYSE:CPB) , with a Zacks Rank #2, has long-term earnings growth rate of 5%.

Kimberly-Clark Corp. (NYSE:KMB) , with an expected long-term earnings growth rate of 5.2%, also carries a Zacks Rank #2.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Kimberly-Clark Corporation (KMB): Free Stock Analysis Report

Avon Products, Inc. (AVP): Free Stock Analysis Report

Nu Skin Enterprises, Inc. (NUS): Free Stock Analysis Report

Campbell Soup Company (CPB): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.